The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

LONDON, GREATER LONDON , UK, July 26, 2024 /EINPresswire.com/ -- The clinical trial imaging market has experienced robust growth in recent years, expanding from $1.32 billion in 2023 to $1.44 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased sales and the distribution of clinical imaging software and services, increased risks of breast cancer, increased healthcare spending, rise in healthcare expenditure results in improved infrastructure, increased research and development spending by the pharmaceutical and biotechnological companies.

Strong Future Growth Anticipated
The clinical trial imaging market is projected to continue its strong growth, reaching $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing chronic diseases, rising research and development expenditures, an increasing geriatric population, a growing number of clinical studies, and an increasing number of contract research organizations.

Explore Comprehensive Insights Into The Global Clinical Trial Imaging Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15765&type=smp

Growth Driver Of The Clinical Trial Imaging Market
The increasing prevalence of chronic diseases is expected to propel the growth of the clinical trial imaging market going forward. Chronic disease is a long-lasting condition that typically requires ongoing medical attention and can limit daily activities or quality of life. The increasing prevalence of chronic diseases is due to exposure to air pollution, chemicals, and toxins, lifestyle changes, and genetic factors. Clinical trial imaging provides efficient monitoring through imaging that can help patients understand their condition and the impact of treatments, improving adherence and satisfaction.

Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

Clinical Trial Imaging Market Major Players And Market Trends
Key players in the clinical trial imaging market include Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation.

Major companies operating in the clinical trial imaging market are developing cloud-based image tools to provide better solutions and improve the efficiency of clinical trials. Cloud-based imaging tools are software applications and platforms that utilize cloud computing technology to store, manage, and analyze medical images.

Clinical Trial Imaging Market Segments:
1) By Product And Services: Services, Software
2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Other Modalities
3) By Application: Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, Other Applications
4) By Distributer: Direct Sales, Tender Sales
5) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Medical Device Manufacturers, Academic And Government Research Institutes, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the clinical trial imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Clinical Trial Imaging Market Definition
Clinical trial imaging refers to the use of medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography scan (CT) scans, and X-rays, to capture detailed internal images of participants during clinical trials. These images help monitor disease progression, assess treatment efficacy, and ensure patient safety. It is a crucial component in evaluating the biological impact of new therapies and interventions.

Clinical Trial Imaging Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Clinical Trial Imaging Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on clinical trial imaging market size, clinical trial imaging market drivers and trends, clinical trial imaging market major players, clinical trial imaging competitors' revenues, clinical trial imaging market positioning, and clinical trial imaging market growth across geographies. The clinical trial imaging market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
AI-Based Clinical Trial Solution Providers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Clinical Data Management Systems (CDMS) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/clinical-data-management-systems-cdms-global-market-report

Preclinical Assets Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/preclinical-assets-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn